PTC Therapeutics Inc. sell Citigroup Inc.
Start price
12.02.25
/
50%
€46.20
Target price
12.02.26
€43.54
Performance (%)
36.36%
Price
12.12.25
€63.00
Summary
This prediction is currently active. The SELL prediction by Citigroup_Inc_ for PTC Therapeutics Inc. is trending in the completely wrong direction and now has a performance of 36.36%. This prediction currently runs until 12.02.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | -3.817% | -3.817% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Citigroup_Inc_ for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at Citigroup Inc. from $32.00 to $45.00. They now have a "sell" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€47.00
04.12.24
04.12.24
€30.40
04.12.25
04.12.25
39.36%
05.12.25
05.12.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€35.40
21.05.24
21.05.24
€23.95
21.05.25
21.05.25
13.56%
22.05.25
22.05.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.60
27.10.23
27.10.23
€16.10
27.10.24
27.10.24
120.45%
28.10.24
28.10.24